PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22218934-0	2012	Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites.	Anthocyanins	120-132	angiotensin I converting enzyme	Homo sapiens	65-94	
22218934-3	2012	The objective of this study was to evaluate the effects of anthocyanins and their breakdown metabolites, protocatechuic, syringic, gallic, and vanillic acids, on different parameters involved in atherosclerosis, including inflammation, cell adhesion, chemotaxis, endothelial function, estrogenic/anti-estrogenic activity, and angiotensin-converting enzyme (ACE) inhibitory activity.	Anthocyanins	59-71	angiotensin I converting enzyme	Homo sapiens	326-355	
22218934-3	2012	The objective of this study was to evaluate the effects of anthocyanins and their breakdown metabolites, protocatechuic, syringic, gallic, and vanillic acids, on different parameters involved in atherosclerosis, including inflammation, cell adhesion, chemotaxis, endothelial function, estrogenic/anti-estrogenic activity, and angiotensin-converting enzyme (ACE) inhibitory activity.	Anthocyanins	59-71	angiotensin I converting enzyme	Homo sapiens	357-360	
22218934-6	2012	All anthocyanins showed an ACE-inhibitory activity.	Anthocyanins	4-16	angiotensin I converting enzyme	Homo sapiens	27-30	
22218934-9	2012	However, the concentrations of anthocyanins and their metabolites, as used in the present cell culture and in vitro assays mediating anti-inflammatory, anti-adhesive, anti-estrogenic, and angiotensin-converting enzyme inhibitory activities, were often manifold higher than those physiologically achievable.	Anthocyanins	31-43	angiotensin I converting enzyme	Homo sapiens	188-217	
19808084-9	2010	CONCLUSIONS: The competitive ACE inhibitor activity of the anthocyanins 1 and 2 is reported for the first time.	Anthocyanins	59-71	angiotensin I converting enzyme	Homo sapiens	29-32